Chikatoshi Yanagimoto
Kurume University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chikatoshi Yanagimoto.
The American Journal of Gastroenterology | 2007
Takumi Kawaguchi; Tatsuya Ide; Eitaro Taniguchi; Eiichi Hirano; Minoru Itou; Shuji Sumie; Yumiko Nagao; Chikatoshi Yanagimoto; Shinichiro Hanada; Hironori Koga; Michio Sata
OBJECTIVES:Hepatitis C virus (HCV) infection is linked to greater insulin resistance. Although HCV itself is a candidate for the development of insulin resistance, the effects of antiviral treatment on impaired glucose metabolism remain unclear. The aim of this study is to examine the effects of clearance of HCV on insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate (IRS)1/2, central molecules for insulin signaling.METHODS:We analyzed 89 biopsy-proven patients with chronic HCV infection. Patients received interferon-α or interferon-α plus ribavirin for 6 months and were classified into three groups at 6 months after the conclusion of antiviral therapy according to their response to antiviral therapy: sustained responders (N = 29), relapsers (N = 12), and nonresponders (N = 48). Insulin resistance and beta-cell function were assessed by the homeostasis model assessment method (HOMA-IR and HOMA-%B, respectively). Hepatic expression of IRS1/2 was evaluated by immunoblotting and immunostaining in 14 sustained responders.RESULTS:In nonresponders and relapsers, there were no significant changes in HOMA-IR and HOMA-%B values after antiviral therapy. On the other hand, in sustained responders, HOMA-IR values significantly decreased to 1.7 ± 0.8 from 3.1 ± 1.1 (P < 0.05) after antiviral therapy. Similarly, HOMA-%B values significantly decreased to 90.6 ± 10.0 from 113.7 ± 15.3 (P < 0.05). Immunoblotting showed a threefold increase in IRS1/2 expression after clearance of HCV. Immunostaining revealed that greater IRS1/2 expression was seen in hepatocytes.CONCLUSIONS:We showed that clearance of HCV improves insulin resistance, beta-cell function, and hepatic IRS1/2 expression.
Cancer | 2008
Michiko Maeyama; Hironori Koga; Karuppaiyah Selvendiran; Chikatoshi Yanagimoto; Shinichiro Hanada; Eitaro Taniguchi; Takumi Kawaguchi; Masaru Harada; Takato Ueno; Michio Sata
Acquired features of cells under epithelial‐mesenchymal transition (EMT) have not yet been fully identified. The current study was conducted to assess alterations in both the proliferative potential and the responsiveness to extracellular matrices (ECMs) in EMT.
Hepatology Research | 2011
Chikatoshi Yanagimoto; Masaru Harada; Hiroto Kumemura; Mitsuhiko Abe; Hironori Koga; Masahiro Sakata; Takumi Kawaguchi; Kunihiko Terada; Shinichiro Hanada; Eitaro Taniguchi; Haruaki Ninomiya; Takato Ueno; Toshihiro Sugiyama; Michio Sata
Aim: Wilson disease is a genetic disorder of copper metabolism characterized by impaired biliary copper excretion. Wilson disease gene product (ATP7B) functions in copper incorporation to ceruloplasmin (Cp) and biliary copper excretion. Our previous study showed the late endosome localization of ATP7B and described the copper transport pathway from the late endosome to trans‐Golgi network (TGN). However, the cellular localization of ATP7B and copper metabolism in hepatocytes remains controversial. The present study was performed to evaluate the role of Niemann–Pick type C (NPC) gene product NPC1 on intracellular copper transport in hepatocytes.
Experimental Cell Research | 2009
Chikatoshi Yanagimoto; Masaru Harada; Hiroto Kumemura; Hironori Koga; Takumi Kawaguchi; Kunihiko Terada; Shinichiro Hanada; Eitaro Taniguchi; Yukio Koizumi; Souichi Koyota; Haruaki Ninomiya; Takato Ueno; Toshihiro Sugiyama; Michio Sata
Wilson disease is a genetic disorder characterized by the accumulation of copper in the body by defective biliary copper excretion. Wilson disease gene product (ATP7B) functions in copper incorporation to ceruloplasmin (Cp) and biliary copper excretion. However, copper metabolism in hepatocytes has been still unclear. Niemann-Pick disease type C (NPC) is a lipid storage disorder and the most commonly mutated gene is NPC1 and its gene product NPC1 is a late endosome protein and regulates intracellular vesicle traffic. In the present study, we induced NPC phenotype and examined the localization of ATP7B and secretion of holo-Cp, a copper-binding mature form of Cp. The vesicle traffic was modulated using U18666A, which induces NPC phenotype, and knock down of NPC1 by RNA interference. ATP7B colocalized with the late endosome markers, but not with the trans-Golgi network markers. U18666A and NPC1 knock down decreased holo-Cp secretion to culture medium, but did not affect the secretion of other secretory proteins. Copper accumulated in the cells after the treatment with U18666A. These findings suggest that ATP7B localizes in the late endosomes and that copper in the late endosomes is transported to the secretory compartment via NPC1-dependent pathway and incorporated into apo-Cp to form holo-Cp.
Biochemical and Biophysical Research Communications | 2008
Hiroto Kumemura; Masaru Harada; Chikatoshi Yanagimoto; Hironori Koga; Takumi Kawaguchi; Shinichiro Hanada; Eitaro Taniguchi; Takato Ueno; Michio Sata
Microtubules (MTs) and microfilaments (MFs) are known to modulate mitochondrial morphology, distribution and function. However, little is known evidence about the role of intermediate filaments (IFs) in modulating mitochondria except desmin. To investigate whether or not the IFs regulate mitochondrial morphology, distribution, and function, we manipulated the IFs of cultured epithelial cells to express a mutant keratin 18 (K18). In contrast to the filamentous expression of wild K18, mutant K18 induced aggregation of K8/18, showing no fine IF network in the cells. In mutant K18-transfected cells, the mitochondria were fragmented into small spheroids, although they were observed as mitochondrial fibers in un-transfected or wild K18-transfected cells. Fluorescence recovery after photobleaching of fluorescence-labeled mitochondria was markedly less in the mutant K18-transfected cells, although a significant recovery was confirmed in wild K18-transfected cells. These findings suggest that the IFs are important for the maintenance of normal mitochondrial structures.
Molecular Medicine Reports | 2010
Masahiro Sakata; Takumi Kawaguchi; Eitaro Taniguchi; Akira Nakayama; Sonoko Ishizaki; Ichiro Sonaka; Miyako Maganuma; Toru Nakamura; Minoru Itou; Tetsuharu Oriishi; Mitsuhiko Abe; Chikatoshi Yanagimoto; Hironori Koga; Masaru Harada; Teruo Sakamoto; Shigeto Oda; Michio Sata
Serum albumin exists in oxidized and reduced forms. Although the oxidation of albumin affects some of its functions, the relationship between oxidized albumin and colloid osmotic pressure (COP) remains unclear. The aim of this study was to determine whether there is an association between oxidized albumin and COP. Blood samples from 20 healthy volunteers were divided into two aliquots in order to prepare reduced (n=20) and oxidized albumin samples (n=20). This was achieved by treatment with L-cysteine and a redox-stabilizing agent before and after incubation at 37°C for 24 h. The percentage of oxidized albumin was determined by high-performance liquid chromatography. COP was measured using a colloid osmometer. Reduced and oxidized albumin samples showed 100% of reduced and 100% of oxidized albumin, respectively. There were no significant differences in albumin level and total protein level between the reduced and the oxidized albumin samples. No significant change was seen in COP between the reduced and the oxidized albumin samples (reduced albumin, 17.4±0.2 mmHg; oxidized albumin, 17.3±0.2 mmHg; P=0.465). Therefore, there is no significant difference in COP between reduced and oxidized albumin samples.
Hepatology Research | 2007
Shinichiro Hanada; Masaru Harada; Takumi Kawaguchi; Hiroto Kumemura; Eitaro Taniguchi; Hironori Koga; Chikatoshi Yanagimoto; Michiko Maeyama; Takato Ueno; Michio Sata
Aim: Mallory bodies have been observed in various liver diseases, however, the precise mechanism and significance of these structures have yet to be determined.
Journal of Hepatology | 2007
Shinichiro Hanada; Masaru Harada; Hiroto Kumemura; M. Bishr Omary; Hironori Koga; Takumi Kawaguchi; Eitaro Taniguchi; Takafumi Yoshida; Takao Hisamoto; Chikatoshi Yanagimoto; Michiko Maeyama; Takato Ueno; Michio Sata
E-spen, The European E-journal of Clinical Nutrition and Metabolism | 2010
Masahiro Sakata; Takumi Kawaguchi; Eitaro Taniguchi; Akira Nakayama; Sonoko Ishizaki; Ichiro Sonaka; Toru Nakamura; Minoru Itou; Tetsuharu Oriishi; Mitsuhiko Abe; Chikatoshi Yanagimoto; Hironori Koga; Michio Sata
The Kurume Medical Journal | 2005
Masaru Harada; Hiroto Kumemura; Chikatoshi Yanagimoto; Michio Sata
Collaboration
Dive into the Chikatoshi Yanagimoto's collaboration.
University of Occupational and Environmental Health Japan
View shared research outputs